S1230 Non-Vitamin K Oral Anticoagulants (NOACs) vs Low Molecular Weight Heparin (LMWH) for the Treatment of Venous Thromboembolism in the Setting of Gastrointestinal and Pancreato-Biliary Malignancies—A Meta-Analysis

Meta Analysis ◽

Oral Anticoagulants ◽

Low Molecular Weight ◽

Biliary Malignancies

How do low-molecular-weight heparin (LMWH), vitamin K agonists (VKAs), and direct oral anticoagulants (DOACs) compare for treatment of venous thromboembolism (VTE) in people with cancer?

Cochrane Clinical Answers ◽

10.1002/cca.2813 ◽

2019 ◽

Author(s):

Simone Mocellin

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Oral Anticoagulants ◽

How do low-molecular-weight heparin (LMWH), vitamin K agonists (VKAs), and direct oral anticoagulants (DOACs) compare for treatment of venous thromboembolism (VTE) in people with cancer?

Cochrane Clinical Answers ◽

10.1002/cca.2255 ◽

2019 ◽

Author(s):

Simone Mocellin

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Oral Anticoagulants ◽

Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis

10.1183/13993003.congress-2020.4977 ◽

2020 ◽

Author(s):

Anna Francesca Mulles ◽

Amraphel Nicolas ◽

Harold Henrison Chiu ◽

Ralph Elvi Villalobos

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Primary Prevention ◽

Cancer Patients ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Meta-analysis of the randomized comparisons between low-molecular weight heparin (LMWH) with oral anticoagulants (OA) for the long-term treatment of symptomatic venous thromboembolism (VTE): no difference in cancer-related mortality

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.8145 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 8145-8145

Author(s):

G. Ferretti ◽

E. Bria ◽

P. Carlini ◽

A. Felici ◽

D. Giannarelli ◽

...

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Term Treatment ◽

Low Molecular Weight ◽

Long Term Treatment ◽

Related Mortality

Direct oral anticoagulants versus low-molecular-weight heparin for acute treatment of venous thromboembolism in patients with gastrointestinal cancer: A systematic review and meta-analysis

10.37766/inplasy2021.8.0113 ◽

2021 ◽

Author(s):

Tarinee Rungjirajittranon ◽

◽

Weerapat Owattanapanich ◽

Yingyong Chinthammitr ◽

Theera Ruchutrakool ◽

...

Keyword(s):

Systematic Review ◽

Molecular Weight ◽

Venous Thromboembolism ◽

Gastrointestinal Cancer ◽

Acute Treatment ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low Molecular Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism

Annals of Hematology & Oncology ◽

10.26420/annhematoloncol.2018.1208 ◽

2018 ◽

Vol 5 (5) ◽

Author(s):

Patel A

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Sickle Cell Disease ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Low Molecular Weight ◽

Cell Disease

Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants

Journal of Thrombosis and Haemostasis ◽

10.1046/j.1538-7836.2003.00364.x ◽

2003 ◽

Vol 1 (9) ◽

pp. 1906-1913 ◽

Cited By ~ 105

Author(s):

A. Iorio ◽

F. Guercini ◽

M. Pini

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Term Treatment ◽

Low Molecular Weight ◽

Long Term Treatment

Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer

The American Journal of Cardiology ◽

10.1016/j.amjcard.2020.07.027 ◽

2020 ◽

Vol 133 ◽

pp. 175-178

Author(s):

Kirtipal Bhatia ◽

Guneesh Uberoi ◽

Navkaranbir S. Bajaj ◽

Vardhmaan Jain ◽

Sameer Arora ◽

...

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Low Molecular Weight ◽

Patients With Cancer

Direct Oral Anticoagulants and Low-Molecular Weight Heparin for Primary Prevention of Venous Thromboembolism in Cancer Patients: A Meta-Analysis

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6045 ◽

2020 ◽

Author(s):

A.F. Mulles ◽

A.L. Nicolas ◽

H.H.C. Chiu ◽

R.E.M. Villalobos

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Primary Prevention ◽

Cancer Patients ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Comparison Between Non–vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism

JAMA Network Open ◽

10.1001/jamanetworkopen.2020.36304 ◽

2021 ◽

Vol 4 (2) ◽

pp. e2036304

Author(s):

Dong-Yi Chen ◽

Chi-Nan Tseng ◽

Ming-Jer Hsieh ◽

Wen-Ching Lan ◽

Cheng-Keng Chuang ◽

...

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽